logo
Mastek share price up 3% on bagging contract from NHS England; details here

Mastek share price up 3% on bagging contract from NHS England; details here

Mastek shares gained in trade today after the company announced it has secured a contract from NHS England to provide cybersecurity training for NHS Boards and Senior Information Risk Owners (SIROs).
SI Reporter New Delhi
Mastek share price: IT company Mastek share price rose as much as 2.90 per cent to hit an intraday high of ₹2,570.15 per share on Tuesday, June 17, 2025.
Around 10:25 AM, Mastek shares were trading 1.22 per cent higher at ₹2,528.10 per share. In comparison, BSE Sensex was trading 0.24 per cent lower at 81,597.09 levels.
Why did Mastek share price rise in trade today?
Mastek shares gained in trade today after the company announced it has secured a contract from NHS England to provide cybersecurity training for NHS Boards and Senior Information Risk Owners (SIROs). The training will be delivered in partnership with Templar Executives, Mastek said, in a statement.
'We are delighted to be partnering with Mastek to deliver training assured by the National Cyber Security Centre (NCSC). With the growing integration of healthcare services, our tailored approach and experience encourages Boards and executives to take accountability for cyber and information risk, alongside clinical and financial risk, to deliver quality patient care,' said Rekha Babber, MD Cyber Academy, Templar Executives.
The training will focus on equipping these critical leaders with the knowledge and skills needed to effectively manage cyber risks, ensure compliance with legislation, and foster a culture of cyber resilience within their organisations.
'We are happy to expand our support into NHS England in building stronger cybersecurity leadership across the NHS. As healthcare systems continue to become more digital, effective cyber governance at the Board level is essential to safeguarding patient data and ensuring the resilience of critical services,' said Abhishek Singh, President of UKI & Europe at Mastek.
The training includes two core components: SIRO Training, which targets SIROs and Deputy SIROs to help them manage cyber risks more effectively; and Board Training, which is designed to improve executive boards' understanding of cybersecurity governance, leadership responsibilities, and regulatory compliance.
The partnership with NHS England highlights the company's focus on enabling secure healthcare services in an increasingly digital environment, Mastek said.
About Mastek
Mastek is a global provider of enterprise AI, digital, and cloud services that help clients generate measurable and sustainable returns on their technology investments. With a presence in over 40 countries and a workforce of more than 5,000 professionals, Mastek serves over 400 active customers across key sectors such as Public Sector, Healthcare, Retail, Manufacturing, Higher Education, and Financial Services.
The company partners with leading technology platforms including Oracle, Salesforce, Microsoft, AWS, Snowflake, and Databricks to deliver innovative solutions tailored to evolving business needs.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Markets trade lower in early deals on profit-taking in blue-chip stocks, foreign fund outflows
Markets trade lower in early deals on profit-taking in blue-chip stocks, foreign fund outflows

The Hindu

time24 minutes ago

  • The Hindu

Markets trade lower in early deals on profit-taking in blue-chip stocks, foreign fund outflows

Benchmark indices Sensex and Nifty declined in early trade on Thursday (July 24, 2025) amid profit-taking in blue-chip stocks and continuous foreign fund outflows. Despite a positive start, the 30-share BSE Sensex failed to carry forward the momentum and fell later in the trade. The benchmark declined 130.92 points to 82,595.72 in early trade. The 50-share NSE Nifty dipped 23 points to 25,196.90. From the Sensex firms, Trent, Kotak Mahindra Bank, UltraTech Cement, Bajaj Finance, Tech Mahindra, Tata Consultancy Services, Infosys and Axis Bank were among the biggest laggards. However, Tata Motors, Eternal, Sun Pharma and Tata Steel were among the gainers. Infosys Ltd on Wednesday (July 23, 2025) reported an 8.7% rise in June quarter net profit and narrowed its full-year revenue forecast after stronger-than-expected earnings growth. In Asian markets, South Korea's Kospi, Japan's Nikkei 225 index, Shanghai's SSE Composite index and Hong Kong's Hang Seng were trading in positive territory. The U.S. markets ended higher on Wednesday (July 23, 2025). India and the U.K. will sign a free trade agreement on Thursday (July 24, 2025) in London that will allow export of labour-intensive products such as leather, footwear and clothing at concessional rates, while making imports of whisky and cars from Britain cheaper. The pact also helps double trade between the two economies to ₹120 billion by 2030. "U.S. striking trade deals with many countries is slowly removing concerns surrounding tariff wars. In the mother market U.S., good corporate earnings are providing the fundamental support to the market. Good Q1 numbers from Infosys can provide support to the weak IT index," VK Vijayakumar, Chief Investment Strategist, Geojit Investments Limited, said. Foreign Institutional Investors (FIIs) offloaded equities worth ₹4,209.11 crore on Wednesday (July 23, 2025), according to exchange data. However, Domestic Institutional Investors (DIIs) bought stocks worth ₹4,358.52 crore in the previous trade. Global oil benchmark Brent crude climbed 0.31% to ₹68.72 a barrel. On Wednesday (July 23, 2025), the Sensex jumped 539.83 points or 0.66% to settle at 82,726.64. The Nifty gained 159 points or 0.63% to settle at 25,219.90.

Supreme Petrochem slips over 2% on weak Q1 results; profit tanks 34% YoY
Supreme Petrochem slips over 2% on weak Q1 results; profit tanks 34% YoY

Business Standard

time24 minutes ago

  • Business Standard

Supreme Petrochem slips over 2% on weak Q1 results; profit tanks 34% YoY

Supreme Petrochem share price today: Petrochemical company Supreme Petrochem share price dropped as much as 2.43 per cent to an intraday low of ₹793.65 per share on Thursday, July 24, 2025. At 10:11 AM, Supreme Petrochem shares were trading 1.33 per cent lower at ₹802.60 per share. In comparison, BSE Sensex was trading 0.28 per cent lower at 82,497.79 levels. Why did Supreme Petrochem share price drop in trade? Supreme Petrochem share price dropped on reporting a weak set of June quarter of financial year 2026 (Q1FY26) results. The company posted a net profit of ₹80.9 crore, down 33.6 per cent year-on-year (Y-o-Y) from ₹121.9 crore in the same quarter last year (Q1FY25). The revenue dropped 11.9 per cent Y-o-Y to ₹1,386.5 crore in the June quarter of FY26, from ₹1,573.4 crore in the June quarter of FY25. At the operating level, Ebitda tanked 29.1 per cent Y-o-Y to ₹114.7 crore in Q1FY26, from ₹161.8 crore in Q1FY25. Ebitda margin squeezed 190 basis points (bps) annually to 8.3 per cent in the June quarter of FY26, as against 10.2 per cent in the June quarter of FY25. About Supreme Petrochem Supreme Petrochem is a leading Indian petrochemical company specialising in the styrenics segment, with a strong focus on polystyrene and related products. A flagship entity of the Rajan Raheja Group, SPL has established itself as the market leader in polystyrene in India, commanding over 50 per cent market share in the domestic segment. The company plays a vital role in supporting downstream plastic processing industries by supplying high-quality raw materials used in a wide range of applications. SPL's product portfolio includes General Purpose Polystyrene (GPPS) and High Impact Polystyrene (HIPS), which are widely used in injection molding, extrusion, thermoforming, and blow molding applications. These materials find end-use across industries such as consumer goods, electronics, packaging, and automotive components. In addition, the company manufactures Expandable Polystyrene (EPS) in multiple variants, including high-expansion, fast cycle, and flame-retardant grades, catering to insulation, protective packaging, and construction sectors. Expanding beyond conventional polystyrene, SPL also produces polymer compounds, which are custom-formulated blends of polymers with additives, reinforcements, and fillers. These engineered compounds are tailored for specific functional and mechanical performance in niche industrial applications. Furthermore, SPL is the first and only producer in India of Extruded Polystyrene (XPS) insulation boards, a high-performance material used for energy-efficient insulation in building and infrastructure projects. On the operational front, Supreme Petrochem runs state-of-the-art manufacturing facilities located in Amdoshi (Maharashtra) and Manali (Chennai), equipped to meet both domestic demand and international standards. The company has built a robust global presence, with exports to over 100 countries, making it the largest exporter of polystyrene from India.

Bikaji Foods pops 3% after posting Q1 results; what should investors do?
Bikaji Foods pops 3% after posting Q1 results; what should investors do?

Business Standard

timean hour ago

  • Business Standard

Bikaji Foods pops 3% after posting Q1 results; what should investors do?

Bikaji Foods International shares rose 3.4 per cent in trade, logging an intraday high at ₹815.25 per share on BSE. The stock was in demand after the company posted its Q1FY26 results. At 9:30 AM, Bikaji Foods share price was trading 2.79 per cent higher at ₹810 per share on BSE. In comparison, BSE Sensex was down 0.14 per cent at 82,612.63. The market capitalisation of the company stood at ₹20,192.76. CATCH STOCK MARKET LIVE UPDATES TODAY Bikaji Foods Q1 results Bikaji Foods reported its Q1FY26 results on Wednesday, July 23, 2025, after market hours. In the June quarter (Q1FY26), Bikaji Foods registered a 9 per cent rise in the consolidated net profit year-on-year (Y-o-Y) to ₹58.5 crore as compared to ₹57.8 crore. Its revenue from operations stood at ₹652.7 crore, up 14 per cent, from ₹571.6 crore a year ago. The Earnings before interest, tax, depreciation and amotisation (Ebitda) stood at ₹96.3 crore as compared to ₹91.6 crore a year ago. Ebitda margin was at 14.8 per cent, as against 16 per cent a year ago. Brokerages' view on Bikaji Foods post Q1 results Emkay Global Financial Services has maintained a 'Buy' call on Bikaji Foods, with a target price of ₹825 per share on the back of the company's continued progress toward the goal of becoming a 'Total Food Company'. Bikaji's growth narrative continued to swiftly improve under its professional management, which has a dual focus of strengthening core operations and enhancing fundamentals through strategic merger and acquisition (M&A) initiatives. The company is in the process of setting up a bakery unit in South India under its wholly owned subsidiary, Bikaji Bakes Pvt Ltd.,' the brokerage note read. Nuvama Institutional Equities also continued with 'Buy', but said that it will revist its estimates and target price post earnings call. Bikaji Foods management commentary 'The company remains confident about the business outlook and is committed to delivering long-term sustainable growth through innovation, market expansion, and deeper consumer engagement,' said Deepak Agarwal, managing director, Bikaji Foods International Limited. About Bikaji Foods International Bikaji Foods International is an ethnic snacks company in India with an international footprint, selling Indian snacks and sweets, and is the second fastest growing company in the Indian organised snacks market. Bikaji Foods' product range includes six principal categories: bhujia, namkeen, packaged sweets, papad, western snacks as well as other snacks which primarily include gift packs (assortment), frozen food, mathri range, and cookies.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store